tetano
Editor, Senior Moderator
Front Immunol
. 2022 Jun 16;13:830061.
doi: 10.3389/fimmu.2022.830061. eCollection 2022.
Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19
Takeshi Ebihara[SUP] 1 [/SUP], Hisatake Matsumoto[SUP] 1 [/SUP], Tsunehiro Matsubara[SUP] 1 [/SUP], Yuki Togami[SUP] 1 [/SUP], Shunichiro Nakao[SUP] 1 [/SUP], Hiroshi Matsuura[SUP] 1 2 [/SUP], Shinya Onishi[SUP] 1 [/SUP], Takashi Kojima[SUP] 3 [/SUP], Fuminori Sugihara[SUP] 4 [/SUP], Daisuke Okuzaki[SUP] 5 [/SUP], Haruhiko Hirata[SUP] 6 [/SUP], Hitoshi Yamamura[SUP] 2 [/SUP], Hiroshi Ogura[SUP] 1 [/SUP]
Affiliations
Abstract
Introduction: Resistin is reported to form a cytokine network and cause endothelial damage. The pathogenesis of coronavirus disease 2019 (COVID-19) remains unknown, but the association between cytokine storm and endothelial damage is crucial. This study aimed to evaluate resistin in COVID-19 pathogenesis compared with sepsis.
Materials and methods: First, we evaluated the association of plasma resistin levels and disease severity and clinical outcome in two large cohorts: a publicly available cohort including 306 COVID-19 patients in the United States (MGH cohort) and our original cohort including only intubated 113 patients in Japan (Osaka cohort 1). Second, to understand pathogenesis, we evaluate resistin, cytokines and endothelial cell adhesion molecules in COVID-19 compared with sepsis. Blood samples were collected from 62 ICU-treated COVID-19 patients and 38 sepsis patients on day 1 (day of ICU admission), days 2-3, days 6-8, and from 18 healthy controls (Osaka cohort 2). The plasma resistin, inflammatory cytokines (IL-6, IL-8, MCP-1 and IL-10) and endothelial cell adhesion molecules (ICAM-1 and VCAM-1) were compared between patients and control. Correlations among resistin, inflammatory cytokines and endothelial cell adhesion molecules were evaluated in COVID-19 and sepsis.
Results: In the MGH cohort, the day 1 resistin levels were associated with disease severity score. The non-survivors showed significantly greater resistin levels than survivors on days 1, 4 and 8. In the Osaka cohort 1, 28-day non-survivors showed significantly higher resistin levels than 28-day survivors on days 6-8. Patients with late recovery (defined as the day of weaning off mechanical ventilation >12 or death) had significantly higher resistin levels than those with early recovery on day 1 and days 6-8. In the Osaka cohort 2, plasma resistin levels were elevated in COVID-19 and sepsis patients compared to controls at all measurement points and were associated with inflammatory cytokines and endothelial cell adhesion molecules.
Conclusion: Resistin was elevated in COVID-19 patients and was associated with cytokines and endothelial cell adhesion molecules. Higher resistin levels were related to worse outcome.
Keywords: COVID-19; cytokine network; cytokines; endothelial damage marker; resistin.
. 2022 Jun 16;13:830061.
doi: 10.3389/fimmu.2022.830061. eCollection 2022.
Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19
Takeshi Ebihara[SUP] 1 [/SUP], Hisatake Matsumoto[SUP] 1 [/SUP], Tsunehiro Matsubara[SUP] 1 [/SUP], Yuki Togami[SUP] 1 [/SUP], Shunichiro Nakao[SUP] 1 [/SUP], Hiroshi Matsuura[SUP] 1 2 [/SUP], Shinya Onishi[SUP] 1 [/SUP], Takashi Kojima[SUP] 3 [/SUP], Fuminori Sugihara[SUP] 4 [/SUP], Daisuke Okuzaki[SUP] 5 [/SUP], Haruhiko Hirata[SUP] 6 [/SUP], Hitoshi Yamamura[SUP] 2 [/SUP], Hiroshi Ogura[SUP] 1 [/SUP]
Affiliations
- PMID: 35784283
- PMCID: PMC9243394
- DOI: 10.3389/fimmu.2022.830061
Abstract
Introduction: Resistin is reported to form a cytokine network and cause endothelial damage. The pathogenesis of coronavirus disease 2019 (COVID-19) remains unknown, but the association between cytokine storm and endothelial damage is crucial. This study aimed to evaluate resistin in COVID-19 pathogenesis compared with sepsis.
Materials and methods: First, we evaluated the association of plasma resistin levels and disease severity and clinical outcome in two large cohorts: a publicly available cohort including 306 COVID-19 patients in the United States (MGH cohort) and our original cohort including only intubated 113 patients in Japan (Osaka cohort 1). Second, to understand pathogenesis, we evaluate resistin, cytokines and endothelial cell adhesion molecules in COVID-19 compared with sepsis. Blood samples were collected from 62 ICU-treated COVID-19 patients and 38 sepsis patients on day 1 (day of ICU admission), days 2-3, days 6-8, and from 18 healthy controls (Osaka cohort 2). The plasma resistin, inflammatory cytokines (IL-6, IL-8, MCP-1 and IL-10) and endothelial cell adhesion molecules (ICAM-1 and VCAM-1) were compared between patients and control. Correlations among resistin, inflammatory cytokines and endothelial cell adhesion molecules were evaluated in COVID-19 and sepsis.
Results: In the MGH cohort, the day 1 resistin levels were associated with disease severity score. The non-survivors showed significantly greater resistin levels than survivors on days 1, 4 and 8. In the Osaka cohort 1, 28-day non-survivors showed significantly higher resistin levels than 28-day survivors on days 6-8. Patients with late recovery (defined as the day of weaning off mechanical ventilation >12 or death) had significantly higher resistin levels than those with early recovery on day 1 and days 6-8. In the Osaka cohort 2, plasma resistin levels were elevated in COVID-19 and sepsis patients compared to controls at all measurement points and were associated with inflammatory cytokines and endothelial cell adhesion molecules.
Conclusion: Resistin was elevated in COVID-19 patients and was associated with cytokines and endothelial cell adhesion molecules. Higher resistin levels were related to worse outcome.
Keywords: COVID-19; cytokine network; cytokines; endothelial damage marker; resistin.